Qvt Financial LP Assembly Biosciences, Inc. Transaction History

Qvt Financial LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$28.58 - $49.91 $1.52 Million - $2.66 Million	-53,280 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $1.23 Million - $1.86 Million	53,280	53,280 $1.86 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $717M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Qvt Financial LP with notifications on news.